SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences receives ‘Site certificate under WHO-GMP certification Scheme’

11 Dec 2019 Evaluate

Kimia Biosciences has been granted ‘Site certificate under WHO-GMP certification Scheme’ by State Drug Controller Haryana, Food and Drug Administration Haryana Panchkula for complying with Goods Manufacturing Practices for Pharmaceutical products for Starting materials namely ‘Active pharmaceutical Ingredients(API) Bulk Drugs’ for Categories- ‘Non Beta Lactum’ for Production, Packing and Quality Control activities. This certificate is valid upto November 17, 2022.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

37.55 -0.73 (-1.91%)
24-Apr-2026 12:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.85
Dr. Reddys Lab 1323.40
Cipla 1285.00
Zydus Lifesciences 930.80
Lupin 2269.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×